Is Perspective Therapeutics, Inc. (CATX) a Buy, Sell, or Hold?
AMEX : CATX
Perspective Therapeutics, Inc. — Competitors
$3 USD
$0.03 (1.01%)
- Volume
- 939.5K
- Average Volume
- 1.75M
- Market Capitalization
- $342.14M
- P/E Ratio
- -0.11
- Dividend Yield
- 0.00%
- Price Target
- $14.00
- Year High
- $6.16
- Year Low
- $1.96
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.75
CATX vs. The Competition
| Properties | CATX | AVR | ELMD | HSDT |
|---|---|---|---|---|
| Market Cap | $342.14M | $866.34M | $349.34M | $98.67M |
| Shares Outstanding | $114.05M | $97.23M | $8.28M | $58.39M |
| P/E Ratio | -0.11 | -2.23 | 34.58 | -0.05 |
| EPS | -107.27 | -4.04 | 1.23 | -1.78 |
| Day Low | 3 | 8.465 | 41.4 | 1.68 |
| Day High | 3.03 | 8.92 | 42.65 | 1.7255 |
| Year Low | 1.96 | 3.175 | 18.55 | 1.185 |
| Year High | 6.16 | 11.055 | 47.4 | 25.5 |
| Average Price 50 | 3.1368 | 9.1048 | 40.4154 | 1.6617 |
| Average Price 200 | 3.502 | 6.43508 | 30.2593 | 2.65223 |
| Volume | 939.5K | 475.59K | 76246 | 62090 |
| Average Volume | - | - | - | - |